I
Ida Strina
Researcher at University of Naples Federico II
Publications - 51
Citations - 1489
Ida Strina is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Thrombophilia & Medicine. The author has an hindex of 22, co-authored 43 publications receiving 1248 citations.
Papers
More filters
Journal ArticleDOI
Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial
G. De Placido,C. Alviggi,Antonino Perino,Ida Strina,F. Lisi,A. Fasolino,R. De Palo,A. Ranieri,Nicola Colacurci,Antonio Mollo +9 more
TL;DR: RLH supplementation is more effective than increasing the dose of rF SH in terms of ovarian outcome in patients with an initial inadequate ovarian response to rFSH alone, according to a multicentre, prospective, randomized trial.
Journal ArticleDOI
High outcome predictability after IVF using a combined score for zygote and embryo morphology and growth rate
Giuseppe De Placido,Martin Wilding,Ida Strina,Erminia Alviggi,Carlo Alviggi,Antonio Mollo,Maria Teresa Varicchio,Achille Tolino,Cristina Schiattarella,Brian Dale +9 more
TL;DR: Early embryo development data suggested that a combination of in-vitro growth rate and morphological analysis both of zygotes and embryos was highly indicative of outcome after IVF.
Journal ArticleDOI
Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH
Giuseppe De Placido,Antonio Mollo,Carlo Alviggi,Ida Strina,Maria Teresa Varricchio,A. Ranieri,Nicola Colacurci,Achille Tolino,Martin Wilding +8 more
TL;DR: It is suggested that LH supplementation improves the ovarian outcome in patients characterized by an inadequate initial response to rFSH therapy in a long protocol.
Journal ArticleDOI
Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation.
G. De Placido,Carlo Alviggi,Antonio Mollo,Ida Strina,A. Ranieri,Erminia Alviggi,Martin Wilding,Maria Teresa Varricchio,A. L. Borrelli,Salvatore Conforti +9 more
TL;DR: This study evaluated the effect of different recombinant LH (rLH) doses on the ovarian outcome of normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation.
Journal ArticleDOI
Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study
Gillian M. Lockwood,Georg Griesinger,Barbara Cometti,Giuseppe De Placido,Carlo Alviggi,A. Ranieri,Ida Strina,Enrico Papaleo,Michela Molgora,Andrea R. Genazzani,Paolo Giovanni Artini,Vito Cela,Nicola Pluchino,Annibale Volpe,Antonio La Marca,Giovanna Sighinolgi,Klaus Diedrich,Luca Gianaroli,Christina Grugnetti,Christian De Geyter,János Urbancsek,Abey Eapen,Guido Ragni,Yacoub Khalaf,Luca Sabatini,Bruno Engl +25 more
TL;DR: Implantation rate, pregnancy rate, live birth rate, and early miscarriage rate for Prolutex were similar to those for Crinone, and the adverse event profiles were similar and prolutex was safe and well tolerated.